Level Zero Health, a healthtech startup based in London and San Francisco, has raised £5.5M in pre-seed funding to build the world's largest hormone health dataset. This funding will facilitate the development of DNA-based sensors for continuous hormone monitoring, moving beyond traditional lab blood tests. The company, founded by experts Ula Rustamova and Irene Jia, aims to revolutionize healthcare in areas like IVF and testosterone therapy. Their innovative technology will provide real-time insights into hormonal health while reducing the burden of frequent invasiveness associated with blood tests.
The company aims to create the world's largest hormone health dataset to drive advanced insights, research, and personalised care.
Level Zero Health is developing DNA-based sensors for remote and continuous hormone monitoring, providing new insights into our body's chemistry.
This innovation could transform healthcare in areas like IVF, menopause, and testosterone replacement therapy, reducing the need for frequent blood tests.
Founded by Ula Rustamova and Irene Jia, the company combines biochemistry and nanotechnology to create a wearable patch for real-time hormone monitoring.
Collection
[
|
...
]